Frontiers in Oncology

Original Research

Accepted on 21 Feb 2025

Trends in gastric cancer burden in the Western Pacific region from 1990 to 2021 and projections to 2040

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Tao Zhang
Yiqun Zhang
Xiaofei Leng

Frontiers in Oncology

doi 10.3389/fonc.2025.1506479

Original Research

Accepted on 21 Feb 2025

Aryl Hydrocarbon Receptor-Regulated Long Non-Coding RNAs: Implications for Glycolipid Metabolism and Prognosis in Hepatocellular Carcinoma

in Molecular and Cellular Oncology

Xiaoli Xiao
Yao Liu
Xiaoyong Qu
Luogen Liu
GuoQing Li
Honghui Chen
Linlin Zhou
Yanping Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1537481

Editorial

Accepted on 21 Feb 2025

Editorial: Targeting and Monitoring Cancer Metabolism: Novel Theranostics for

in Cancer Metabolism

Nobu OSHIMA
Yuki Aisu
Akihiko Masuo
Yoichi Takakusagi
Tatsuya Kawai

Frontiers in Oncology

doi 10.3389/fonc.2025.1575563

Original Research

Accepted on 21 Feb 2025

A nomogram for predicting overall survival in oral squamous cell carcinoma: A SEER database and external validation study

in Head and Neck Cancer

Ziye Xu
Manbin Xu
Zhichen Sun
Qin Feng
Shaowei Xu
Hanwei Peng

Frontiers in Oncology

doi 10.3389/fonc.2025.1557459

Original Research

Accepted on 21 Feb 2025

Global and East Asia Tracheal, bronchus, and lung cancer Trend Analysis from 1990 to 2021 and Forecast Trend from 2021 to 2035

in Cancer Epidemiology and Prevention

Jian Ding
Weizhen Guo
Qian Xue
Gang Cheng
Lu Zhang
Di Wu
Yating Gao
Cheng Yang
Jiabing Tong
Zegeng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1542067

Review

Accepted on 21 Feb 2025

Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis

in Head and Neck Cancer

Xiaojuan Zhong
Yujie Fei
Haihui Zhao
Jiao Chen
Mingyu Gao
Yi Huang
Wei Fei

Frontiers in Oncology

doi 10.3389/fonc.2025.1529225

Original Research

Accepted on 21 Feb 2025

AI-Enhanced Cancer Radiotherapy Quality Assessment: Utilizing Daily Linac Performance, Radiomics, Dosimetrics, and Planning Complexity

in Radiation Oncology

Jia Deng
Yaolin Zhao
Dengdian Huang
Qingju Zhang
Ye Hong
Xiangyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1503188

Review

Accepted on 21 Feb 2025

A review on the role of MiR-193a-5p in oncogenesis and tumor progression

in Molecular and Cellular Oncology

Weixiang Tang
Yuhua Rao
Longsheng Pi
Jin-ping Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1543215

Review

Accepted on 21 Feb 2025

Chemokines and Their Receptors in the Esophageal Carcinoma Tumor Microenvironment: Key Factors for Metastasis and Progression

in Molecular and Cellular Oncology

Pan Liu
Zhiqiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2025.1523751

Case Report

Accepted on 21 Feb 2025

Anlotinib for the Treatment of Recurrent and Refractory Hemangioblastomas: A Case Report and Review of Literature

in Neuro-Oncology and Neurosurgical Oncology

Qing Tian
Chaofeng Zhou
Shifan Zhou
Sai Wang
Baorong Feng
Keke Zhang
Yu Zhang
Jieqiong Gao
Xiaoyan Mu
Zhizhong Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1508226

Original Research

Accepted on 21 Feb 2025

Association between neutrophil-to-lymphocyte ratio and all-cause and cardiovascular mortality among adults with cancer from NHANES 2005-2018: a retrospective cohort study

in Cardio-Oncology

Gangping Li
Yuewen Fu
Di Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1521099

Original Research

Accepted on 21 Feb 2025

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer: A Phase 1b Study

in Breast Cancer

Sara M Tolaney
Komal Jhaveri
Teresa Helsten
Shannon Puhalla
Alison Conlin
E Claire Dees
Muralidhar Beeram
Sonya C Chapman
Andrew Lithio
Lacey M Litchfield

Frontiers in Oncology

doi 10.3389/fonc.2025.1555921

Correction

Accepted on 21 Feb 2025

Corrigendum: Diagnostic Performance of microRNAs for Predicting Response to Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma: A Meta-Analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

CuiHua Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1578891

Mini Review

Accepted on 21 Feb 2025

The Potential Role of BCL-2 Inhibition in Amyloidosis and Plasma Cell Leukemia

in Hematologic Malignancies

Grigorios Alvanidis
Dimitrios Kotsos
Christina Frouzaki
Amalia Fola
Evdoxia Hatjiharissi

Frontiers in Oncology

doi 10.3389/fonc.2025.1549891

Original Research

Accepted on 21 Feb 2025

Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Qinqin Song
Hongjiao Wu
Ye Jin
Junzhi Hou
Jiawei Liu
Xuemei Zhang
Wanning Hu
Guogui Sun
Zhi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1503133

Systematic Review

Accepted on 21 Feb 2025

GDF-15 as a Biomarker for Diagnosis and Prognosis of Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Teng Pan
Zihan Xu
Xiaohan He
Xiaojin Luo
Guanglin Zhou
Yu Song
Jinhai Deng
Xuerui Tan
Fengxiang Wei

Frontiers in Oncology

doi 10.3389/fonc.2025.1447990

Navigation group

Articles

Trends in gastric cancer burden in the Western Pacific region from 1990 to 2021 and projections to 2040

Aryl Hydrocarbon Receptor-Regulated Long Non-Coding RNAs: Implications for Glycolipid Metabolism and Prognosis in Hepatocellular Carcinoma

Editorial: Targeting and Monitoring Cancer Metabolism: Novel Theranostics for

A nomogram for predicting overall survival in oral squamous cell carcinoma: A SEER database and external validation study

Global and East Asia Tracheal, bronchus, and lung cancer Trend Analysis from 1990 to 2021 and Forecast Trend from 2021 to 2035

Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis

AI-Enhanced Cancer Radiotherapy Quality Assessment: Utilizing Daily Linac Performance, Radiomics, Dosimetrics, and Planning Complexity

A review on the role of MiR-193a-5p in oncogenesis and tumor progression

Chemokines and Their Receptors in the Esophageal Carcinoma Tumor Microenvironment: Key Factors for Metastasis and Progression

Anlotinib for the Treatment of Recurrent and Refractory Hemangioblastomas: A Case Report and Review of Literature

Association between neutrophil-to-lymphocyte ratio and all-cause and cardiovascular mortality among adults with cancer from NHANES 2005-2018: a retrospective cohort study

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer: A Phase 1b Study

Corrigendum: Diagnostic Performance of microRNAs for Predicting Response to Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma: A Meta-Analysis

The Potential Role of BCL-2 Inhibition in Amyloidosis and Plasma Cell Leukemia

Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway

GDF-15 as a Biomarker for Diagnosis and Prognosis of Lung Cancer: A Meta-Analysis